These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 33969238)

  • 1. Randomized controlled trials of remdesivir in hospitalized coronavirus disease 2019 patients: A meta-analysis.
    Sarfraz A; Sarfraz Z; Sanchez-Gonzalez M; Michel J; Michel G; Frontela O; Posada J; Cardona J; Angueira E
    Turk J Emerg Med; 2021; 21(2):43-50. PubMed ID: 33969238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remdesivir for the treatment of COVID-19.
    Ansems K; Grundeis F; Dahms K; Mikolajewska A; Thieme V; Piechotta V; Metzendorf MI; Stegemann M; Benstoem C; Fichtner F
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014962. PubMed ID: 34350582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Remdesivir for the treatment of COVID-19.
    Grundeis F; Ansems K; Dahms K; Thieme V; Metzendorf MI; Skoetz N; Benstoem C; Mikolajewska A; Griesel M; Fichtner F; Stegemann M
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD014962. PubMed ID: 36695483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhou F; Zhang D; Zhao J; Du R; Hu Y; Cheng Z; Gao L; Jin Y; Luo G; Fu S; Lu Q; Du G; Wang K; Lu Y; Fan G; Zhang Y; Liu Y; Ruan S; Liu W; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Trials; 2020 May; 21(1):422. PubMed ID: 32448345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Meta-Analysis of Association between Remdesivir and Mortality among Critically-Ill COVID-19 Patients.
    Razzack AA; Hassan SA; Pasya SKR; Erasani G; Kumar S; Rocha-Castellanos DM; Lopez-Mendez A; Razzack SA
    Infect Chemother; 2021 Sep; 53(3):512-518. PubMed ID: 34508325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remdesivir: A Review in COVID-19.
    Blair HA
    Drugs; 2023 Sep; 83(13):1215-1237. PubMed ID: 37589788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
    Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Wang Y; Zhang D; Du G; Du R; Zhao J; Jin Y; Fu S; Gao L; Cheng Z; Lu Q; Hu Y; Luo G; Wang K; Lu Y; Li H; Wang S; Ruan S; Yang C; Mei C; Wang Y; Ding D; Wu F; Tang X; Ye X; Ye Y; Liu B; Yang J; Yin W; Wang A; Fan G; Zhou F; Liu Z; Gu X; Xu J; Shang L; Zhang Y; Cao L; Guo T; Wan Y; Qin H; Jiang Y; Jaki T; Hayden FG; Horby PW; Cao B; Wang C
    Lancet; 2020 May; 395(10236):1569-1578. PubMed ID: 32423584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ivermectin for preventing and treating COVID-19.
    Popp M; Reis S; Schießer S; Hausinger RI; Stegemann M; Metzendorf MI; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Jun; 6(6):CD015017. PubMed ID: 35726131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety, tolerability and mortality reduction efficacy of remdesivir; based on randomized clinical trials, observational and case studies reported safety outcomes: an updated systematic review and meta-analysis.
    Santenna C; Vidyasagar K; Amarneni KC; Ghanta SN; Sadasivam B; Pathan S; Padmavathi R
    Ther Adv Drug Saf; 2021; 12():20420986211042517. PubMed ID: 34594487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Meta-Analysis of Safety of Different Regimens of Remdesivir in COVID-19 Patients.
    Konwar M; Maurya M; Bose D
    Curr Drug Saf; 2022; 17(2):158-167. PubMed ID: 34323191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of remdesivir in patients with COVID-19: a protocol for systematic review and meta-analysis of randomised controlled trials.
    Gebrie D; Getnet D; Manyazewal T
    BMJ Open; 2020 Jun; 10(6):e039159. PubMed ID: 32503874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS Med; 2020 Sep; 17(9):e1003293. PubMed ID: 32941437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ivermectin for preventing and treating COVID-19.
    Popp M; Stegemann M; Metzendorf MI; Gould S; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD015017. PubMed ID: 34318930
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for treatment of COVID-19: Second edition of a living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    Juul S; Nielsen EE; Feinberg J; Siddiqui F; Jørgensen CK; Barot E; Holgersson J; Nielsen N; Bentzer P; Veroniki AA; Thabane L; Bu F; Klingenberg S; Gluud C; Jakobsen JC
    PLoS One; 2021; 16(3):e0248132. PubMed ID: 33705495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis.
    Lee TC; Murthy S; Del Corpo O; Senécal J; Butler-Laporte G; Sohani ZN; Brophy JM; McDonald EG
    Clin Microbiol Infect; 2022 Sep; 28(9):1203-1210. PubMed ID: 35598856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remdesivir for Adults With COVID-19 : A Living Systematic Review for American College of Physicians Practice Points.
    Wilt TJ; Kaka AS; MacDonald R; Greer N; Obley A; Duan-Porter W
    Ann Intern Med; 2021 Feb; 174(2):209-220. PubMed ID: 33017170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.
    Reis S; Metzendorf MI; Kuehn R; Popp M; Gagyor I; Kranke P; Meybohm P; Skoetz N; Weibel S
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD015395. PubMed ID: 36126225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.